MedPlus Health Services Limited (formerly known as MedPlus Health Services
Annexure- VIL

Notes to Restated Consolidated Financial Information

(All amounts are it Rs. in millions except as others stated)

48. Details of CSR expenditure

 

 

September302021 September 302020 __ March 31,2021__March 31,2020 March 31,2019
(2) Gross amount required to be spent by the Group during the period/year 436 352 as ai 407
(© Amount approved by the Board to be spent during the priod/year 496 332 sas aaa 407
{6) Amount spent during the period/year (in cash)

(0) Constraction/ acquisition of any aset 3 2 - s 5

(i) On purposes other than (i) above 228 1.00 4a an 407
(6) (honall)/ Excess at the end of the period /year 268 aa - 2 3
{c) Total of previous years shortfall Nil Nil Nit Nil Nil
(0 Details of related party transactions Nil Nil Nit Nil Nil
() Where a provision is made with respect toa liability incurred by entering int a contractual
obligation, the movements i the provision during the period/ year.

Nil Nil Nit Nil Nil

(hi) Reason for shortfall:

For the year ending March 31, 2021, March 31, 2020 & March 31, 2019: No shortfall

For the period ended September 30, 2021 and September 30,2020, The Company was in the
process of identifying prospective project as per schedule VI of the Companies Act, 2013

() Nature of CSR activities:
§) Payment to Prime minister national relief fund
i) Education

iil) Hunger management

iv) Covid activities

Note: The Group does not have any ongoing projects and accordingly no disclosure has been made inthis regard

49. Acqui

 

ion of subsidiary and non-controlling interests

(On September 24, 2019, the Group acquired additional 29.88% of the voting rights and obtained control of board of directors of Kalyani Meditimes Private Limited (‘Kalyani Meditimes") engaged in the business of
development of healthcare software. The total investment by the Group in Kalyani Meditimes Private Limited as at 30 September 2021 stands at 65

 

Control over Kalyani Meditimes will enable the Group to technological advancements process through enhanced solutions in healthcare, The acquisition is expected to provide Group with an increased share of
pharmacy market through access to Kalyani Meditimes customer base. The Group also expects to reduce costs through economies of scale.

‘Such business combination has been accounted for by the Group in accordance with Ind AS 103 - Business Combination as follows:
a) all assets andl liabilities pertaining to Kalyani Meditimes transferred to the Company have been recorded at ther fair values as at September 24, 2019;
}) the purchase consideration has been recorded at fair value; and

©) the difference between the purchase consideration and the net identifiable assets as per (a) above has been recorded as capital reserve.

‘The acquired business contributed revenues of Rs, 0.1 millions and loss before tax of Rs. 3.7 millions to the Group for the period September 24, 2019 to March 31, 2020. Ifthe acquisitions had occurred on April 1, 2019,
ppro-forma revenue and loss before tax forthe year ended March 31, 2020 would have been Rs. 0.1 millions and Rs. 14.27 respectively

4) Identifiable assets acquired and liabilities assumed at fair values
‘The following table summarises the recognised fair value amounts of assets acquired and liabilities assumed as on date of acquisition:

 

 

Particulars Total
Tatangible assets 0
Intangible assets under development 1914
Cash and bank equivalents 0.07
Other assets ot
Other current liabilities (ay

 

Total net ident

 

le assets acquived 198

 

‘Measurement of fair values
“Assets acquired Valuation techniques
Intangible assets and Intangible assets Multi-Period Excess Earnings Method (MEEM):
under development ‘The valuation of intangible asset and intangible assets under development under MEM depends upon the projections of the future aftertax cash flows from the each
identified individual intangible asset, rates of contributory asset charges, life ofthe each identified intangible asset and selection ofthe appropriate discount factor

 

  

 

‘The fair value of Kalyani Meditimes's intangible assets has been determined by the Registered valuer vide their report dated October 15, 2019 basis the nature of business and provisional financial statements for the six
months period ended September 23, 2019, projected financial information the period pertaining to FY 2020-2005 provided by the Management and also the market data pertaining to economy, industry and business
management.

») Recognition of capi

 

reserve on bargain purchase
Capital reserve arising from the acquisition has been recognised as follows

 

 

 

Particulars ‘Amount
‘Consideration paid in cash 300
Less:

Fair value of net identifiable assets acquired as on date of acquisition 19.81

Non-controlling interest towards net identifiable assets on date of acquisition (13.89) 592
Capital reserve o)

 

 

 

) Acquisition of Non-Controlling Interest ("NCI")
(Over the years 2019-20 and 2020-21, the Group acquired an 65.59% shareholding in Kalyani Meditimes for Rs. 5 millions,

4) Movement in Non-Controlling Interest

 

 

 

 

 

 

 

 

 

 

 

 

Particulars Amount
‘Non controlling interest on date of acquisition a8
Change in ownership interests in subsidiaries without loss of control 297
Share of profit for the period September 24,2019 to March 31, 2020 G86)
‘Non controlling interest 73.00
‘Share of profit for the sx months period ended 30 September 20) B25)
‘Non controlling interest as at 30 September 2020 378

‘Share of profit for the year ended 31 March 2021 C5)
‘Non controlling interest as at 31 March 2021 551

‘Share of profi for the sx months period ended 50 September 2027 Cay
‘Non controlling interest as at 30 September 2021 a7

 

 
